Synaptic integration mediated by striatal cholinergic interneurons in basal ganglia function.

The physiological role of striatal cholinergic interneurons was investigated with immunotoxin-mediated cell targeting (IMCT). Unilateral cholinergic cell ablation caused an acute abnormal turning behavior. These mice showed gradual recovery but displayed abnormal turning by both excess stimulation and inhibition of dopamine actions. In the acute phase, basal ganglia function was shifted to a hyperactive state by stimulation and suppression of striatonigral and striatopallidal neurons, respectively. D1 and D2 dopamine receptors were then down-regulated, relieving dopamine-predominant synaptic perturbation but leaving a defect in controlling dopamine responses. The acetylcholine-dopamine interaction is concertedly and adaptively regulated for basal ganglia synaptic integration.

[1]  H. Fibiger,et al.  D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons , 1992, Neuroscience.

[2]  O. Hikosaka.  Models of information processing in the basal Ganglia edited by James C. Houk, Joel L. Davis and David G. Beiser, The MIT Press, 1995. $60.00 (400 pp) ISBN 0 262 08234 9 , 1995, Trends in Neurosciences.

[3]  G. E. Alexander,et al.  Functional architecture of basal ganglia circuits: neural substrates of parallel processing , 1990, Trends in Neurosciences.

[4]  S. Tonegawa,et al.  Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice , 1994, Cell.

[5]  D L Price,et al.  Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. Delong,et al.  Functional and pathophysiological models of the basal ganglia , 1996, Current Opinion in Neurobiology.

[7]  A M Graybiel,et al.  The basal ganglia and adaptive motor control. , 1994, Science.

[8]  J. Penney,et al.  The functional anatomy of basal ganglia disorders , 1989, Trends in Neurosciences.

[9]  C. Gerfen,et al.  D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. , 1990, Science.

[10]  C. Pycock.  Turning behaviour in animals , 1980, Neuroscience.

[11]  Micaela Morelli,et al.  Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions , 1994, Trends in Neurosciences.

[12]  B. Bloch,et al.  Fos Immunoreactivity after Stimulation or Inhibition of Muscarinic Receptors Indicates Anatomical Specificity for Cholinergic Control of Striatal Efferent Neurons and Cortical Neurons in the Rat , 1993, The European journal of neuroscience.

[13]  M Hallett,et al.  Physiology of Basal Ganglia Disorders: An Overview , 1993, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[14]  A. Graybiel.  Building action repertoires: memory and learning functions of the basal ganglia , 1995, Current Opinion in Neurobiology.

[15]  S P Wise,et al.  Distributed modular architectures linking basal ganglia, cerebellum, and cerebral cortex: their role in planning and controlling action. , 1995, Cerebral cortex.

[16]  M. Chesselet,et al.  Basal ganglia and movement disorders: an update , 1996, Trends in Neurosciences.

[17]  T. Robbins,et al.  Neurobehavioural mechanisms of reward and motivation , 1996, Current Opinion in Neurobiology.

[18]  R. Mark Wightman,et al.  Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter , 1996, Nature.

[19]  J. E. Vaughn,et al.  Immunocytochemical localization of choline acetyltransferase within the rat neostriatum: A correlated light and electron microscopic study of cholinergic neurons and synapses , 1985, The Journal of comparative neurology.

[20]  R. Burke,et al.  Antimuscarinic drugs in the treatment of movement disorders. , 1990, Progress in brain research.

[21]  D. Surmeier,et al.  Are neostriatal dopamine receptors co-localized? , 1993, Trends in Neurosciences.

[22]  J. Cadet,et al.  Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in rats , 1991, Brain Research Bulletin.

[23]  I. Pastan,et al.  Immunotoxin-mediated conditional disruption of specific neurons in transgenic mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[24]  C. Gerfen,et al.  Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior , 1998, Experimental Brain Research.

[25]  K. Toyama,et al.  Ablation of Cerebellar Golgi Cells Disrupts Synaptic Integration Involving GABA Inhibition and NMDA Receptor Activation in Motor Coordination , 1998, Cell.

[26]  S. Nakanishi,et al.  Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat , 1993, Neuroscience.

[27]  B. Bloch,et al.  D1 and D2 dopamine receptor gene expression in the rat striatum: Sensitive cRNA probes demonstrate prominent segregation of D1 and D2 mRNAS in distinct neuronal populations of the dorsal and ventral striatum , 1995, The Journal of comparative neurology.

[28]  J. McGinty,et al.  Intrastriatal injection of a muscarinic receptor agonist and antagonist regulates striatal neuropeptide mRNA expression in normal and amphetamine-treated rats , 1997, Brain Research.

[29]  C. Gerfen,et al.  Dopaminergic and muscarinic regulation of striatal enkephalin and substance P messenger RNAs following striatal dopamine denervation: Effects of systemic and central administration of quinpirole and scopolamine , 1994, Neuroscience.

[30]  A. Saiardi,et al.  Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors , 1995, Nature.

[31]  Hans Forssberg,et al.  Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons , 2000, Nature Neuroscience.